Sionna Therapeutics, Inc.
SION
$12.14
-$0.46-3.65%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
4/24/2025
-
MarketBeat
4/23/2025
-
MarketBeat
4/23/2025
-
Ticker Report
4/8/2025
-
24/7 Wall St.
4/4/2025
-
MarketBeat
3/27/2025
-
Ticker Report
3/26/2025
-
MarketBeat
3/25/2025
-
MarketBeat
3/25/2025
-
ETF Channel
3/22/2025
-
MarketBeat
3/21/2025
-
TipRanks Financial Blog
3/21/2025
-
MarketBeat
Sionna Therapeutics (NASDAQ:SION) Posts Quarterly Earnings Results, Misses Expectations By $0.70 EPS
3/21/2025
-
MarketBeat
3/20/2025
-
GuruFocus
3/20/2025
-
The Fly
3/20/2025
-
The Fly
3/20/2025
-
Globe Newswire
3/18/2025
-
Ticker Report
3/15/2025
-
Insider Monkey
3/15/2025
-
MarketBeat
3/12/2025
-
MarketBeat
3/12/2025
-
Insider Monkey
3/12/2025
-
MarketBeat
3/11/2025
-
MarketBeat
3/7/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Thursday, March 20, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of Mar 16 and 20 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
--
90-Day Total Return
--
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
617 819 2020
Address
21 Hickory Drive
Waltham, MA 02451
Waltham, MA 02451
Country
Year Founded
Business Description
Sector
Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF). It develops galicaftor (SION-2222), a...
more